x
ServiziMenu principaleHome
You are here: Home > Educational Opportunities > Past events > 2021 > 7th ESO Prostate Cancer Observatory - Innovations and care in the next 12 months
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

7th ESO Prostate Cancer Observatory - Innovations and care in the next 12 months

Not eligible for ESCO credits

12.07.2021

EAU 21 Virtual

OBSERVATORY

Description

Chairs: S. Gillessen, CH – R. Millman, UK

The European School of Oncology is pleased to announce the 7th edition of "ESO Prostate Cancer Observatory: innovation and care in the next 12 months", which will be held during the Virtual EAU21 Congress (8-12 July 2021)

AIMS AND OBJECTIVES

ESO Observatories are high level sessions organised during major international congresses with the aim of providing the audience with updated and unbiased information on a given topic. An ESO Observatory lasts about one hour and concentrates on a forecast given by panel of experts of what it is expected to happen in their own field in the coming 12 months. The Panel includes distinguished clinicians and/or scientists a patient advocate and a nurse.
The forecast by each Panel Member is given in the form of concise take-home messages with a 3-4 minute slide presentation followed by a 1-2 minute discussion for each topic.

The Observatory will be held during the

 

Under the auspices of

 

Information

ESO SECRETARIAT
Laura Richetti
European School of Oncology
Piazza Indipendenza 2
6500 Bellinzona
Switzerland
Email: lrichetti@eso.net
Tel: +41 91 820 09 51

FURTHER INFORMATION
Attendance is granted to all participants registered to the Virtual EAU21 Congress. https://eaucongress.uroweb.org/

For registration please click here.

Faculty

INVITED SPEAKERS

Jelle Barentsz, Radboud UMC, Radiology and Nuclear Medicine Dept., Nijmegen, NL
Elena Castro, Hospital Universitario Virgen de la Victoria, Oncology Dept, Málaga, ES
Eva Compérat, Hopital Tenon - Sorbonne University, Pathology Dept., Paris, FR
Philip Cornford, Liverpool University UK L7 8XP, Dept of Urology, Liverpool, UK
Gert De Meerleer, University Gent, Dept. of Radiotherapy, Gent, BE
Stefano Fanti, Policlinico S.Orsola – Via Massarenti 9 –, PAD 30 –, Bologna, IT
Silke Gillessen, IOSI - Istituto Oncologico della Svizzera Italiana, Medical Oncology dept., Bellinzona, CH
Steven Joniau, University Hospitals Leuven, Dept. of Urology, Leuven, BE
Robin Millman, Stockton-on-Tees, UK
Rafael Sanchez Salas, ’Institut Mutualiste Montsouris, Paris, France, Department of Urology, Paris, FR
Corinne Tillier, Netherlands Cancer Institute, Urology Dpt., Amsterdam, NL
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), Genitourinary Dept., Bellizona, CH

Programme

12 July

13:30Welcome and Introduction
Silke Gillessen, CH - Robin Millman, UK
13:35The urologist’s perspective on surgery
Steven Joniau, BE
13:40The urologist’s perspective on active surveillance
Philip Cornford, UK
13:45The radiation oncologist’s perspectiv
Gert De Meerleer, BE
13:50The medical oncologist’s perspective
Ursula Vogl, CH
13:55The pathologist’s perspective
Eva Compérat, FR
14:00The geneticist’s perspective
Elena Castro, ES
14:05The imaging specialist’s perspective on PSMA-PET/CT
Stefano Fanti, IT
14:10The imaging specialist’s perspective on MRI
Jelle Barentsz, NL
14:20The nurse’s perspective
Corinne Tillier, NL
14:25The patient’s perspective
Robin Millman, UK